Cholinergic stimulation may mitigate arrhythmic risk during treatment of COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholinergic stimulation may mitigate arrhythmic risk during treatment of COVID-19

Published:2020-07-20 Issue:4 Volume:5 Page:147-148
ISSN:2574-9838
Container-title:International Physical Medicine & Rehabilitation Journal
language:
Short-container-title:IPMRJ

Author:

Castro Renata RT^ORCID,Orsini Neves Marco Antonio^ORCID,Silveira Neto João Giffoni da^ORCID,Castro Roberta RT^ORCID

Publisher

MedCrave Group, LLC

Subject

General Medicine

Reference15 articles.

1. Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells;Traebert;Eur J Pharmacol,2004

2. van den Broek MPH, Möhlmann JE, Abeln BGS, et al. Chloroquine-induced QTc prolongation in COVID-19 patients. Neth Heart J. 2020:1-4.

3. FDA. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. FDA; 2020.

4. Sapp JL, Alqarawi W, MacIntyre CJ, et al. Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of covid-19: a statement from the canadian heart rhythm society. Can J Cardiol. 2020.

5. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society;Al-Khatib;J Am Coll Cardiol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP